Studying the Effectiveness of ETGBD Using a Fully Covered Metal Stent to Prevent Acute Cholecystitis in Adults with Low Cystic Duct Insertion

What this Trial Is About

Researchers are evaluating the effectiveness of a procedure called endoscopic transpapillary gallbladder drainage ETGBD using a fully covered self-expandable metal stent FCSEMS to prevent acute cholecystitis in patients whose cystic duct joins the lower part of the common bile duct. The trial aims to compare how well this treatment prevents complications like cholecystitis by measuring the frequency, severity, and need for additional invasive procedures. The study involves placing the FCSEMS alongside the ETGBD through an endoscopic biliary drainage tunnel in patients with low cystic duct insertion. This approach is hypothesized to better prevent cholecystitis compared to other methods. Participants will receive this device-based treatment during the study period. Participants will be monitored for two months after stent placement to observe the incidence rate of acute cholecystitis. The study will gather information on complications and the need for further invasive procedures. The total duration of participation includes this follow-up period to assess treatment outcomes and safety under clinical observation.

Prevention of Acute Cholecystitis With ETGBD